Welcome to our dedicated page for Astronics SEC filings (Ticker: ATROB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for Astronics Corporation (ATROB), a New York corporation that reports material events and financing activities through forms such as Form 8-K. These filings give detailed information on the company’s securities, including convertible senior notes, related derivative transactions, and key contractual terms.
In a recent Form 8-K, Astronics Corporation disclosed the issuance of 0% Convertible Senior Notes due 2031, governed by an indenture with a corporate trustee. The filing explains how these notes rank relative to other indebtedness, the conditions for conversion into cash or common stock, potential redemption by the company, and circumstances under which noteholders may require repurchase following a Fundamental Change. It also outlines events of default and the possibility of Special Interest as a remedy for certain reporting-related defaults.
The same Form 8-K describes capped call transactions that are intended to reduce potential dilution upon conversion of the notes and/or offset certain cash payments above principal, subject to a cap. It further details the use of proceeds, including repurchases of existing convertible senior notes and payments for capped call transactions, as well as the exempt nature of the offering under the Securities Act and Rule 144A.
On Stock Titan, users can review Astronics Corporation’s 8-K filings and related exhibits, such as the indenture, form of notes, capped call confirmations, and press releases. AI-powered tools can help summarize lengthy documents, highlight key terms in the indenture, and clarify how specific items—like unregistered sales of equity securities or new debt obligations—affect the company’s capital structure and potential dilution.
Capital International Investors has filed a Schedule 13G reporting a passive ownership stake in Astronics Corp. common stock. The firm is deemed to beneficially own 1,849,886 shares, representing 5.9% of Astronics’ 31,619,410 shares believed to be outstanding as of the reported date.
The filing states Capital International Investors has sole voting and dispositive power over all 1,849,886 shares and no shared power. It also certifies the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Astronics.
American Century Investment Management and related entities reported a significant ownership position in Astronics Corporation. They disclosed beneficial ownership of 1,764,235 shares of Astronics common stock, representing 5.6% of the outstanding class as of December 31, 2025.
American Century and its parent American Century Companies, Inc., together with the Stowers Institute for Medical Research, reported sole voting power over 1,453,455 shares and sole dispositive power over 1,764,235 shares, with no shared voting or dispositive power. They certified that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics.
PEABODY MARK reported disposition transactions in a Form 4 filing for ATRO. The filing lists transactions totaling 2,500 shares. Following the reported transactions, holdings were 183,445 shares.
State Street Corporation has disclosed a significant ownership position in Astronics Corp common stock. It reports beneficial ownership of 1,832,179 shares, representing 5.8% of Astronics’ common stock as of 12/31/2025.
State Street has shared voting power over 1,755,956 shares and shared dispositive power over 1,832,179 shares, with no sole voting or dispositive power. The firm states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics.
Astronics Corporation filed a current report to note that on February 5, 2026 it issued a news release announcing preliminary unaudited adjusted EBITDA margins for the fourth quarter and full year of 2025. The company also highlighted plans to webcast its presentations at the TD Cowen Aerospace & Defense Conference.
BlackRock, Inc. has filed an amended Schedule 13G showing a significant passive stake in Astronics Corp common stock. As of 12/31/2025, BlackRock reports beneficial ownership of 2,749,452 shares, representing 8.7% of the outstanding common stock. BlackRock has sole voting power over 2,701,240 shares and sole dispositive power over all 2,749,452 shares, with no shared voting or dispositive power.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics. Various underlying clients have rights to dividends or sale proceeds, but no single client has more than five percent of Astronics’ outstanding common shares.
Astronics Corporation issued senior unsecured notes that produced approximately $216.7 million of net proceeds. The company used about $26.9 million to pay for capped call transactions and, together with $85.0 million of borrowings under its ABL Revolving Credit Facility and $11.0 million of cash on hand, repurchased approximately $132.0 million principal amount of its 5.500% Convertible Senior Notes due 2030. The new Notes, issued under an indenture, mature on January 15, 2031, bear no regular interest and do not accrete. Conversion rights are limited prior to October 15, 2030, and on conversion the company may settle with cash and/or shares subject to the terms. The company entered into capped call transactions with option counterparties to reduce potential dilution, with an initial cap price near $83.4051 per share. The Indenture includes customary Events of Default, repurchase rights on Fundamental Change, and specified redemption windows.